The Clinical Relevance of Cellular Drug Resistance Testing in Childhood Acute Myeloid Leukemia (AML)

Pediatric Research - United States
doi 10.1203/00006450-199905010-00212
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Epidemiology of Childhood Acute Myeloid Leukemia

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2013English

Treatment of Childhood Acute Myeloid Leukemia in Bulgaria

Folia Medica
Medicine
2018English

Sex Disparity in Childhood and Young Adult Acute Myeloid Leukemia (AML) Survival: Evidence From US Population Data

Cancer Epidemiology
Cancer ResearchEpidemiologyOncology
2015English

FLT3-TKD Mutation in Childhood Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2003English

Drug Repurposing for the Treatment of Acute Myeloid Leukemia

Frontiers in Medicine
Medicine
2017English

In Vitro Cellular Drug Resistance in Children With Relapsed/Refractory Acute Lymphoblastic Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
1995English

Acute Myeloid Leukemia Drug Development in the Post‐Venetoclax Era

American Journal of Hematology
Hematology
2019English

Second Malignancy After Treatment of Childhood Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2001English

A Summary of the Molecular Testing Recommended in Acute Myeloid Leukemia

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy